VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma.
TENG, MINGXING
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma.
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma. J Clin Oncol. 2017 Dec 01; 35(34):3815-3822.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Female
Humans
Ipilimumab
Male
Maximum Tolerated Dose
Melanoma
Middle Aged
Neoplasm Invasiveness
Neoplasm Staging
Patient Safety
Prognosis
Randomized Controlled Trials as Topic
Retrospective Studies
Skin Neoplasms
Survival Analysis
authors with profiles
JOHN KIRKWOOD